Barriers to access of hematopoietic stem cell transplantation
an integrative review
DOI:
https://doi.org/10.46765/2675-374X.2023v4n3p217Keywords:
Barriers to access of health services, Health services accessibility, Access to essential medicines and health technologies, Bone marrow transplantation, Hematopoietic stem cell transplantation, ReviewAbstract
Introduction: Hematopoietic stem cell transplantation is a therapy for which even countries with universal health systems face challenges to ensure its access to the population. Barriers to access can be characterized as geographic, organizational, socioeconomic and of information. Objective: To conduct an integrative review of barriers to access of hematopoietic stem cell transplantation. Methods: Databases chosen were BVS, PubMed and Scopus. Population and phenomenon were established, respectively as “hematopoietic stem cell transplantation” and “barriers to access” with descriptors in Portuguese and English. 22 articles, published between 2012 and 2022, were selected. Results: Access was hampered by the distance to transplant center, in more populous regions, with high demand for services and transportation difficulties. There was better access in countries with higher GDP per capita, more installed transplant centers and for the population with higher income. Insurance coverage, support by public policies, assistance in academic centers, organized regulation and prioritization of emergencies facilitated access. The understanding of the diseases, the adherence to the treatments, the perception of survival by the patients and the skills of the professionals improved the access. Conclusion: All categories of access barriers were addressed, with multifactorial and interrelated origins, with the vulnerable population being the most affected.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
License and Copyright Policy
The Journal of Bone Marrow Transplantation and Cellular Therapy (JBMTCT) adopts an open access policy, ensuring that all published articles are freely available to the public without restrictions.
-
License
- All articles published in JBMTCT are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
- This license permits anyone to:
- Share: Copy and redistribute the material in any medium or format.
- Adapt: Remix, transform, and build upon the material for any purpose, even commercially.
- The only requirement is that appropriate credit is given to the original authors and source, a link to the license is provided, and any changes made are indicated.
More information about the license can be found here: Creative Commons Attribution 4.0 International License.
-
Authors’ Rights
- Authors retain the copyright to their work.
- Authors grant JBMTCT the right to publish the work and make it openly accessible online.
- Authors are free to:
- Distribute the published version of their article (e.g., post it on personal websites or institutional repositories).
- Use the article in future works, presentations, or derivative publications, as long as the original publication in JBMTCT is properly acknowledged.
-
No Embargo
- There is no embargo period; articles are made freely available immediately upon publication.
-
Ethical Use
- Users of JBMTCT articles must ensure proper citation of the authors and the journal.
- Articles must not be used in ways that violate ethical or legal standards.
-
Disclaimer
- While JBMTCT aims to ensure the accuracy and reliability of published content, the journal and its editors are not responsible for the consequences of its use.
For any questions regarding our licensing terms, please contact us at: journalbmtct@sbtmo.org.br
JBMTCT is committed to the principles of open access to advance knowledge and scientific collaboration.
